Liposomal doxorubicin vs conservative management
All‐cause mortality · HIV‐infected adults with severe (T1) Kaposi's sarcoma
Liposomal doxorubicin showed no clear difference in mortality compared with conservative management (moderate certainty).
1 finding from 1 review
- Treatment of severe or progressive Kaposi's sarcoma in HIV‐infected adults 2014 · Cochrane Headline outcomes onlyRR 0.93 [0.75, 1.15]1 study · 29 participantsModerate